Patents by Inventor Rajeev Vibhakar

Rajeev Vibhakar has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ANTI-CD99 CAR-T CELLS FOR THE TREATMENT OF CANCER
    Publication number: 20250032616
    Abstract: The present disclosure provides compositions and methods directed to anti-CD99 CAR-T therapies for treating cancer, such as DIPG. Ewing Sarcoma, and AML.
    Type: Application
    Filed: March 11, 2024
    Publication date: January 30, 2025
    Inventors: Sujatha VENKATARAMAN, Rajeev VIBHAKAR
  • METHOD OF TREATING MEDULLOBLASTOMA WITH AN EZH2 INHIBITOR
    Publication number: 20200268765
    Abstract: The disclosure provides a method of treating a medulloblastoma in a subject in need thereof comprising administering to the subject a therapeutically-effective amount of an enhancer of a zeste homolog 2 (EZH2) inhibitor. In a preferred embodiment of this method, the subject is pediatric and the EZH2 inhibitor is Tazemetostat.
    Type: Application
    Filed: January 31, 2020
    Publication date: August 27, 2020
    Inventors: Heike KEILHACK, Nigel J. WATERS, Rajeev VIBHAKAR
  • METHOD OF TREATING MEDULLOBLASTOMA WITH AN EZH2 INHIBITOR
    Publication number: 20190083504
    Abstract: The disclosure provides a method of treating a medulloblastoma in a subject in need thereof comprising administering to the subject a therapeutically-effective amount of an enhancer of a zeste homolog 2 (EZH2) inhibitor. In a preferred embodiment of this method, the subject is pediatric and the EZH2 inhibitor is Tazemetostat.
    Type: Application
    Filed: October 5, 2016
    Publication date: March 21, 2019
    Applicants: Epizyme, Inc., The Regents of the University of Colorado, A Body Corporate
    Inventors: Heike KEILHACK, Nigel J. WATERS, Rajeev VIBHAKAR
  • Diagnosis and Treatment of Brain Cancer
    Publication number: 20070148666
    Abstract: Certain genes are silenced in medulloblastoma. These genes include WIF1, sFRP1 and Dkk1. By detecting the expression of at least one of these genes, it is possible to diagnose cancer or to determine whether the cancer is recurring after treatment. Diagnostic methods, methods of treatment, and kits are provided.
    Type: Application
    Filed: September 15, 2006
    Publication date: June 28, 2007
    Inventors: Rajeev Vibhakar, Anup Madam, Beverly Davidson